Retrospective Study
Copyright ©The Author(s) 2015.
World J Cardiol. Mar 26, 2015; 7(3): 150-156
Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.150
Table 3 Five years follow-up
AmplatzerCardioseal/STARflex
5 yr follow-up available, n (%)58 (76.3)23 (82.1)
New-onset SVT
0-1 yr5 (6.6)5 (17.9)
> 1 yr3 (3.9)0
Reoccurrence TIA/stroke
0-1 yr01 (3.6)
> 1 yr2 (2.6)0
TTE > 5 yr FU available, n4611
RLS
No shunt38 (82.6)6 (54.5)
Minimal5 (10.9)3 (27.3)
Moderate1 (2.2)2 (18.2)
Severe2 (4.3)0
LRS00
Follow up (yr)6.6 (5.0-11.1)9.9 (6.3-13.4)